Key result
The introduction of non-vitamin K antagonists and advances in interventional electrophysiological therapies have significantly improved the medical approach to treating atrial fibrillation.
This review summarizes current paradigms in atrial fibrillation management, highlighting advances in interventional electrophysiology and non-vitamin K antagonist oral anticoagulants.
Atrial fibrillation is a frequent arrhythmia with increasing prevalence. The paper reviews the most important present aspects and paradigms in the treatment of the arrhythmia. The main aim of treatment is directed to improve the quality of life while reducing morbidity and mortality. A large experience derived from epidemiological registers and clinical research, impressive advances in interventional electrophysiological therapies and the introduction of non-vitamin K antagonists had a dramatic impact on the medical approach. Recommended steps to classify and treat atrial fibrillation are presented and discussed.
No takes yet. Share an insight, caveat, or question.
Cocco et al. (2015) conducted a review in Atrial fibrillation. Atrial fibrillation therapies (NOACs, antiarrhythmics, ablation) was evaluated. The introduction of non-vitamin K antagonists and advances in interventional electrophysiological therapies have significantly improved the medical approach to treating atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: